The FDA's Final Rule on Expedited Safety Reporting: Statistical Considerations.
Wittes J, Crowe B, Chuang-Stein C, Guettner A, Hall D, Jiang Q, Odenheimer D, Xia HA, Kramer J.
Wittes J, et al. Among authors: odenheimer d.
Stat Biopharm Res. 2015 Jul 3;7(3):174-190. doi: 10.1080/19466315.2015.1043395. Epub 2015 Oct 9.
Stat Biopharm Res. 2015.
PMID: 26550466
Free PMC article.